Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
OBJECTIVE: The goal of this study was to develop a 99mTc labelled human epidermal growth factor (hEGF) for the in-vivo prediction of cancer cell response to farnesyltransferase inhibitor (FTI) therapy. This is based on the observation that internalization of EGF receptors is inhibited by FTIs. METH...
Main Authors: | Cornelissen, B, Kersemans, V, Burvenich, I, Oltenfreiter, R, Vanderheyden, J, Boerman, O, Vandewiele, C, Slegers, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
by: Cornelissen, B, et al.
Published: (2004) -
Comparison of uptake
99mTcO4; 99mTc-DTPA and 99mTc-MDP by breast cancer cell line.
by: Rafzi, Siti Noraisyah
Published: (2015) -
Comparison of uptake 99mTcO4; 99mTc-dtpa and "mTc-mdp by breast cancer cell line.
by: Rafzi, Siti Noraisyah
Published: (2015) -
123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
by: Cornelissen, B, et al.
Published: (2004) -
123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
by: Kersemans, V, et al.
Published: (2006)